Abiomed (ABMD)

Updated: 27 Sep 2021

Entry level: Tested and found support at rising 50-day MA last week. Break above $253 on stronger volume could be a valid entry

Price target: $276 and/or using 10 and 21-day MA’s as a sell guide

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .